Are there any treatments or cures for von Hippel-Lindau syndrome?
Von Hippel-Lindau disease has no cure. The goal of treatment is to find and remove tumors as early as possible, before they affect your health. Your provider may recommend surgery to remove tumors whenever possible. Some tumors may respond to radiation therapy.
Which part of the eye is affected by von Hippel-Lindau disease?
Description. Von Hippel-Lindau (VHL) disease is an autosomal dominantly inherited multisystem cancer syndrome with a predilection for the central nervous system (CNS) and the retina.
What is retinal Hemangioblastoma?
Retinal hemangioblastomas are tumors in the retina, caused by the unchecked growth of leaky, irregular blood vessels. They are one of the most common VHL manifestations, affecting about 60% of VHL patients, and are frequently one of the earliest to present themselves.
What is retinal Angioma?
Retinal angiomas are benign vascular hamartomatous lesions with important systemic and visual implications. Early diagnosis and treatment of retinal angiomas with an appropriate systemic workup for associated systemic diseases can prevent visual loss and morbidity and mortality.
What is a von Hippel Lindau clinic?
von Hippel Lindau (VHL) Clinic. The VHL Clinic brings together a group of expert clinicians with broad experience in treating von Hippel Lindau (VHL) disease. Doctors trained in urology, neurosurgery, neurology, ophthalmology, endocrinology, pediatrics and medical oncology work together to provide coordinated, expert care.
Why choose MDMD Anderson for von Hippel Lindau disease surgery?
MD Anderson’s surgeons are among the most skilled and renowned in the world. They perform a large number of surgeries for von Hippel Lindau disease each year, using the least-invasive and most-advanced techniques. If you are diagnosed with VHL, your treatment will depend on the problems it causes.
What research is being done to treat von Hippel-Lindau disease (VHL)?
The NIH’s National Cancer Institute conducts research aimed at treating kidney tumors in individuals with VHL, as well as studies to identify gene mutations in people who are at risk of developing the disease. Von Hippel-Lindau disease (VHL) is a rare, genetic multi-system disorder in which non-cancerous tumors grow in certain parts of the body.
What causes von Hippel–Lindau syndrome (VHL)?
Von Hippel–Lindau (VHL) is an uncommon autosomal dominant syndrome caused by a germline mutation in the VHL gene that has been mapped to chromosome 3p25. This is the only gene currently known to cause VHL. 1 The product of this gene, pVHL, functions as a tumor suppressor protein much like…
https://www.youtube.com/watch?v=v6cJB43iwyE